BRAF V600E Confers Male Sex Disease-Specific Mortality Risk in Patients With Papillary Thyroid Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Journal of Clinical Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
BRAF V600E Confers Male Sex Disease-Specific Mortality Risk in Patients With Papillary Thyroid Cancer
J. Clin. Oncol 2018 Aug 02;[EPub Ahead of Print], F Wang, S Zhao, X Shen, G Zhu, R Liu, D Viola, R Elisei, E Puxeddu, L Fugazzola, C Colombo, B Jarzab, A Czarniecka, AK Lam, C Mian, F Vianello, L Yip, G Riesco-Eizaguirre, P Santisteban, CJ O'Neill, MS Sywak, R Clifton-Bligh, B Bendlova, V Sýkorová, Y Wang, M XingFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.